Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Fox

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
British Journal of Haematology|March 1, 1992
Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG-CSF)L J Campbell, D W Maher, D L Tay, et al.
Cancer Clinical Trials|January 1, 1981
Cyclical combination chemotherapeutic regimen in adult soft tissue sarcomaD N Dalley, J A Levi, R A Nesbitt, et al.
Thorax|May 1, 1985
Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancerR Stuart-Harris, R M Fox, D Raghavan, et al.
Australian and New Zealand Journal of Medicine|June 1, 1987
Chemotherapy for small cell lung cancer: induction and reinduction with VOCAR Stuart-Harris, D Raghavan, R M Fox, et al.
International Journal of Antimicrobial Agents|July 1, 1996
Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patientsH M Lazarus, R J Creger, R Gucalp, et al.
American Journal of Clinical Oncology|June 17, 1998
Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I studyG C Toner, M Green, J F Bishop, et al.
The Medical Journal of Australia|May 3, 1980
Cis-platinum treatment of metastatic adrenal carcinomaM H Tattersall, H Lander, B Bain, et al.
Cancer Research|February 1, 1990
Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administrationG J Lieschke, D Maher, M O'Connor, et al.
FEBS Letters|November 11, 1985
Lipid domain in cancer cell plasma membrane shown by 1H NMR to be similar to a lipoproteinP G Williams, M A Helmer, L C Wright, et al.
Growth Factors (Chur, Switzerland)|May 9, 2000
A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancerI D Davis, D W Maher, J S Cebon, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
British Journal of Haematology|March 1, 1992
Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG-CSF)L J Campbell, D W Maher, D L Tay, et al.
Cancer Clinical Trials|January 1, 1981
Cyclical combination chemotherapeutic regimen in adult soft tissue sarcomaD N Dalley, J A Levi, R A Nesbitt, et al.
Thorax|May 1, 1985
Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancerR Stuart-Harris, R M Fox, D Raghavan, et al.
Australian and New Zealand Journal of Medicine|June 1, 1987
Chemotherapy for small cell lung cancer: induction and reinduction with VOCAR Stuart-Harris, D Raghavan, R M Fox, et al.
International Journal of Antimicrobial Agents|July 1, 1996
Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patientsH M Lazarus, R J Creger, R Gucalp, et al.
American Journal of Clinical Oncology|June 17, 1998
Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I studyG C Toner, M Green, J F Bishop, et al.
The Medical Journal of Australia|May 3, 1980
Cis-platinum treatment of metastatic adrenal carcinomaM H Tattersall, H Lander, B Bain, et al.
Cancer Research|February 1, 1990
Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administrationG J Lieschke, D Maher, M O'Connor, et al.
FEBS Letters|November 11, 1985
Lipid domain in cancer cell plasma membrane shown by 1H NMR to be similar to a lipoproteinP G Williams, M A Helmer, L C Wright, et al.
Growth Factors (Chur, Switzerland)|May 9, 2000
A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancerI D Davis, D W Maher, J S Cebon, et al.
Pageof 19